According to Gram Research analysis, a naturally occurring compound called indole-3-propionic acid (IPA), made by gut bacteria, reduced atherosclerosis plaque buildup in mice and protected human blood vessel cells from damage by activating cellular cleanup processes. The compound works by binding to a specific protein called 14-3-3θ, which restores the cell’s ability to remove damaged mitochondria and prevent harmful cell death.
Scientists discovered that a natural substance made by gut bacteria called indole-3-propionic acid (IPA) may help prevent atherosclerosis, a disease where plaque builds up in arteries. In studies with mice and human cells, IPA activated a cleanup system inside cells that removes damaged parts, which helped protect blood vessel walls from damage. The research identified exactly how IPA works at the molecular level, targeting a specific protein that helps coordinate this cellular cleanup. These findings suggest that boosting this gut-derived compound could offer a new way to protect heart health, though human studies are still needed to confirm the benefits.
Key Statistics
A 2026 research study found that indole-3-propionic acid (IPA) reduced arterial plaque burden in high-fat diet-fed mice while increasing collagen content in vessel walls, suggesting improved structural integrity of blood vessels.
In laboratory studies of human blood vessel cells, IPA enhanced PINK1/Parkin-mediated mitophagy (cellular cleanup) and prevented PANoptosis (a harmful cell death process) triggered by oxidized LDL cholesterol.
Researchers identified that IPA’s protective effects depend on binding to the 14-3-3θ protein; when this protein was removed in mice, IPA’s anti-atherosclerotic efficacy was significantly attenuated.
The study demonstrated that oxidized cholesterol weakens the connection between the 14-3-3θ protein and PINK1, disrupting cellular cleanup, which IPA treatment restored in human endothelial cells.
The Quick Take
- What they studied: Whether a natural compound made by gut bacteria can prevent atherosclerosis (plaque buildup in arteries) and how it works to protect blood vessels
- Who participated: Mice genetically prone to atherosclerosis that ate a high-fat diet, plus human blood vessel cells grown in the lab and exposed to damaged cholesterol
- Key finding: The compound IPA reduced plaque buildup in arteries, improved how cells clean up damaged parts, and prevented a harmful cell death process in blood vessel cells
- What it means for you: This research suggests that increasing levels of this gut-derived compound through diet or supplements might help protect against heart disease, but human studies are needed before recommendations can be made
The Research Details
This was a multi-part laboratory study published in 2026 that combined animal experiments with cell culture work. Researchers first tested IPA in mice that were genetically prone to developing atherosclerosis and fed a high-fat diet. They examined the mice’s arteries to measure plaque buildup and tissue damage. Next, they studied how IPA worked in human blood vessel cells that were exposed to oxidized LDL (damaged cholesterol), which is known to harm arteries. The researchers used advanced techniques to identify exactly which protein IPA targets and how it works at the molecular level.
Understanding the exact mechanism—the step-by-step process—of how IPA protects blood vessels is crucial because it helps scientists develop better treatments. By identifying the specific protein target (14-3-3θ), researchers can now design drugs that mimic IPA’s effects or find ways to boost the body’s natural production of this compound. This approach is more likely to lead to safe, effective treatments than simply giving people the compound without understanding how it works.
The study used multiple complementary approaches to confirm findings: animal models, human cell cultures, and advanced molecular identification techniques. The researchers validated their findings by removing the target protein in mice to confirm it was necessary for IPA’s protective effects. However, this is laboratory research, not human clinical trials, so results may not directly translate to people. The study was published in a peer-reviewed journal, which means other experts reviewed the work before publication.
What the Results Show
In mice fed a high-fat diet, oral IPA treatment reduced the amount of plaque buildup in arteries, decreased fatty deposits, and increased collagen (a structural protein that strengthens vessel walls). In human blood vessel cells exposed to damaged cholesterol, IPA enhanced mitophagy—the cell’s natural cleanup process that removes damaged mitochondria (the cell’s energy factories). This cleanup process is controlled by two proteins called PINK1 and Parkin, and IPA made this system work better. Additionally, IPA prevented a harmful type of cell death called PANoptosis, which occurs when blood vessel cells are damaged by oxidized cholesterol.
The researchers identified that IPA works by binding to a protein called 14-3-3θ (also called YWHAQ). When oxidized cholesterol damages blood vessels, it weakens the connection between this protein and PINK1, disrupting the cell’s cleanup system. IPA restores this connection, allowing the cleanup process to work again. When researchers removed the 14-3-3θ protein from mice, IPA’s protective effects were significantly reduced, confirming this protein is essential for how IPA works.
Previous research showed that IPA is produced by gut bacteria and has antioxidant properties, but its specific role in protecting blood vessels was unknown. This study is the first to identify the exact molecular target and mechanism of IPA in atherosclerosis prevention. The findings align with growing evidence that gut bacteria-derived compounds play important roles in heart health and that enhancing cellular cleanup processes can prevent atherosclerosis.
This research was conducted in laboratory settings and animals, not in humans. Mice don’t always respond to treatments the same way people do. The study doesn’t tell us how much IPA people would need to consume or whether dietary sources provide enough. It’s unclear whether IPA would work as well in people with existing atherosclerosis or only in prevention. Long-term safety and effectiveness in humans remain unknown and require clinical trials.
The Bottom Line
Based on this research, there is not yet enough evidence to recommend IPA supplements for heart disease prevention in humans. The findings are promising and warrant human clinical trials, but people should not change their treatment plans based on this laboratory research. Current evidence-based recommendations for preventing atherosclerosis remain: maintain a healthy diet, exercise regularly, manage stress, avoid smoking, and follow your doctor’s advice. If interested in gut health, eating fiber-rich foods that feed beneficial bacteria is a safe, evidence-based approach.
This research is most relevant to people interested in heart disease prevention, researchers studying gut bacteria and cardiovascular health, and pharmaceutical companies developing new atherosclerosis treatments. People with existing heart disease or high cholesterol should continue following their doctor’s treatment plans. This is not yet applicable to general health recommendations.
In the animal studies, IPA showed effects over several weeks of treatment. If human trials are conducted, it would likely take months to years to see measurable changes in atherosclerosis progression. Any new treatment would need to go through multiple phases of human testing before becoming available, which typically takes 5-10 years.
Frequently Asked Questions
What is indole-3-propionic acid and where does it come from?
Indole-3-propionic acid (IPA) is a natural compound produced by beneficial gut bacteria when they break down tryptophan, an amino acid from food. It’s found in the digestive system and enters the bloodstream, where it may have protective effects on blood vessels and heart health.
Can I get more IPA by eating certain foods?
IPA is produced by your own gut bacteria, not found directly in foods. However, eating high-fiber foods like vegetables, whole grains, beans, and fruits feeds the bacteria that produce IPA. Increasing fiber intake naturally boosts your body’s IPA production.
Is IPA safe to take as a supplement?
While this research is promising, IPA supplements haven’t been tested for safety and effectiveness in humans yet. Laboratory studies show potential benefits, but human clinical trials are needed before supplements can be recommended. Consult your doctor before taking any new supplements.
How does IPA help prevent heart disease?
IPA activates a cellular cleanup system called mitophagy that removes damaged parts of cells. In blood vessel cells damaged by cholesterol, this cleanup process prevents harmful cell death and maintains vessel health, potentially reducing atherosclerosis progression.
When will IPA treatments be available for patients?
This research is still in the laboratory stage. Before any IPA-based treatment reaches patients, it must go through human clinical trials, which typically take 5-10 years. Current heart disease prevention relies on diet, exercise, and medications proven safe in humans.
Want to Apply This Research?
- Track daily fiber intake (target 25-35 grams) and note any digestive changes, as fiber feeds the gut bacteria that produce IPA. Users could log servings of high-fiber foods like vegetables, whole grains, and legumes.
- Add one high-fiber food to each meal: a vegetable with breakfast, whole grain with lunch, and legumes or fruit with dinner. This supports gut bacteria that naturally produce IPA.
- Monitor energy levels, digestion, and cardiovascular markers (if available through health tracking). Over 8-12 weeks, users should notice improved digestion and potentially better energy as gut health improves. Connect with periodic cholesterol and blood pressure checks through healthcare providers.
This research describes laboratory and animal studies, not human clinical trials. The findings are preliminary and should not be used to guide personal health decisions. IPA supplements are not approved by regulatory agencies for treating or preventing heart disease. Anyone with cardiovascular disease, high cholesterol, or concerns about atherosclerosis should consult their healthcare provider before making changes to their treatment plan. This article is for educational purposes only and does not constitute medical advice.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.